The Voice of Rheumatology (VOR) Coalition convened last month at ACR Convergence 2024 in Washington, D.C., to discuss the pressing federal and state legislative priorities that will affect both the practice of rheumatology and patient care in the year ahead. The Coalition, composed of leading rheumatology professional societies and patient advocacy groups, gathered to examine…
RheumPAC Helps ACR ‘Stand Up for What’s Important’
Kaitlyn Brittan, MD, the newest chair of the ACR’s RheumPAC Committee, views advocacy as a core principle of caring for patients, with meaningful, real-world impact.
Can Cultural Humility Conquer Systemic Inequity in Pediatric Rheumatology?
Doctors and patient advocates urged the rheumatology community to address the drastic inadequacies in care faced by marginalized people in a session held at ACR Convergence 2024.
Multiple ACR-Supported Policies Advance at Interim AMA House of Delegates Meeting
At a busy and highly successful interim meeting of the AMA House of Delegates, an ACR-cosponsored resolution that calls for exceptions to therapy caps was passed and will become AMA policy. Other areas addressed include payment parity for telemedicine and MIPS reform.
Unless Congress Acts, Medicare Reimbursement Will Remain Flat or Drop in 2025
The 2025 Medicare Physician Fee Schedule final rule, released Nov. 1, includes a conversion factor of $32.3465, a 2.83% drop from 2024. In response to advocacy efforts from the ACR and other medical societies, Congress recently introduced the Medicare Patient Access and Practice Stabilization Act of 2024, which would eliminate the 2.83% payment cut and provide an inflationary update for 2025 equal to 50% of the Medicare Economic Index.
2024 Election Summary, Outlook for the Lame Duck Session & the New Congress
With a likely Republican majority in the House and Senate and a Republican president, there may be a sense that the party has a mandate to lead initiatives and enact significant policy changes. Any end-of-year legislative package will be narrower than initially expected, but the ACR’s top priority remains addressing cuts to physician reimbursements.
ATAP Board Appointments for 2024-25 Include 2 Distinguished ACR Members
The Alliance for Transparent and Affordable Prescriptions’ board members for the 2024–25 cycle include Marcus Snow, MD, and Howard Blumstein, MD, who both have a strong history of volunteer leadership in the ACR.
After Coalition Meeting, CMS Leadership Agrees to Closer Look at Underwater Biosimilars
The Underwater Biosimilars Coalition shared with the Centers for Medicare & Medicaid Services concerns about problems arising from the average sales price payment methodology and discussed potential options for addressing these challenges.
Interim AMA House of Delegates Meeting Will Discuss Rheumatology Priorities
At the November meeting, the ACR will advance a resolution that addresses increasing access to telemedicine services for Medicare beneficiaries.
The ACR Joins Members of Congress in Call for Medicare Reimbursement Reform
A letter from 233 bipartisan members of Congress last week urged House leadership to replace the 2.8% cut proposed in the FY2025 Physician Fee Schedule with an annual payment update reflective of inflationary pressures before the end of the year. Boost this effort by contacting your legislator today.
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 96
- Next Page »